Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study

Clicks: 561
ID: 117717
2002
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #1 of 14 articles by views in American journal of hematology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
1998, a consensus meeting was held in Miyazaki, Japan, to develop an approach to management of febrile neutropenia (FN). The K-HOT study group decided to examine whether this proposal was applicable to clinical practice in a multicenter study. Patients who developed fever with neutrophil counts < …
Reference Key
k2002americancefepime Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tamura K;Matsuoka H;Tsukada J;Masuda M;Ikeda S;Matsuishi E;Kawano F;Izumi Y;Uike N;Utsunomiya A;Saburi Y;Shibuya T;Imamura Y;Hanada S;Okamura S;Gondoh H; ;;
Journal American journal of hematology
Year 2002
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/12447952
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine algorithms adult female male Drug Administration Schedule Comparative Study Clinical Trial Multicenter Study controlled clinical trial drug therapy neutropenia / drug therapy* fever / etiology* neutropenia / etiology anti-bacterial agents / therapeutic use* combination / therapeutic use* cephalosporins / therapeutic use* aminoglycosides cefepime pmid:12447952 doi:10.1002/ajh.10236 k tamura h matsuoka kyushu hematology organization for treatment (k-hot) study group carbapenems / administration & dosage carbapenems / therapeutic use* cephalosporins / administration & dosage leukemia / physiopathology lymphoma / physiopathology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.